<DOC>
	<DOCNO>NCT00832117</DOCNO>
	<brief_summary>The purpose study determine high dose ixabepilone give safely cisplatin without cause severe life-threatening side effect patient non-small cell lung cancer , effect ( good bad ) cancer also study</brief_summary>
	<brief_title>Phase I Combination Ixabepilone + Cisplatin</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Epothilones</mesh_term>
	<criteria>Escalation Phase Subjects : Primary solid tumor curable local measure surgery , radiation Men woman age ≥ 18 Exclusion : More 2 prior chemotherapy contain regimen metastatic disease No prior exposure cisplatin ixabepilone Expansion Phase Subjects : Advanced Nonsmall cell lung cancer Men woman age ≥ 18 Exclusion : No prior chemotherapycontaining regimen metastatic disease No prior exposure cisplatin ixabepilone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Lung Cancer ( NSCLC )</keyword>
</DOC>